Mycovia Pharmaceuticals was formed in 2018 following the acquisition of Viamet Pharmaceuticals by NovaQuest Capital Management. At Mycovia, we are passionate about developing breakthrough therapies in women’s health and dermatology.
Our lead product candidate, VT-1161, is being developed as a treatment for recurrent vulvovaginal candidiasis (RVVC), a yeast infection that affects millions of women each year and often leads to distressing physical discomfort and a negative impact on psychological well-being. In studies to date, VT-1161 has demonstrated a high degree of potency against the organisms that cause RVVC. It may also have a lesser tendency to induce drug resistance and the variety of side effects that limit the use of currently available oral antifungal therapies. We are conducting global Phase 3 clinical trials in RVVC.
VT-1161 has also been studied in onychomycosis, a fungal infection of the nail which affects approximately 35 million people in the United States and millions more around the globe. Onychomycosis can be a significant medical issue particularly for diabetics or other patients with compromised immune systems or poor circulation of the lower extremities.
Company Details
- Employees
- 18
- Founded
- -
- Address
- 4505 Emperor Blvd, Durham,north Carolina 27703,united States
- Phone
- 919-467-8539
- in****@****via.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- mycovia.com
- HQ
- Durham, North Carolina
Mycovia Pharmaceuticals Questions
Mycovia Pharmaceuticals's helpline number is 919-467-8539
Mycovia Pharmaceuticals's website is mycovia.com
Mycovia Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/mycovia-pharmaceuticals
Mycovia Pharmaceuticals has
18 employees.
View email and phone details for 18
employees at Mycovia Pharmaceuticals.
Mycovia Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Mycovia Pharmaceuticals's top competitors are
Viamet Pharmaceuticals,
Dendreon,
Scynexis, Inc.,
Apogee Therapeutics,
Amicus Therapeutics,
Veloxis Pharmaceuticals, Inc.,
Novaquest Capital Management,
Elion Therapeutics,
Phathom Pharmaceuticals,
Sprout Pharmaceuticals, Inc..
Mycovia Pharmaceuticals's support email address is info@mycovia.com
Mycovia Pharmaceuticals's categories are Pharmaceutical Manufacturing
Mycovia Pharmaceuticals's founding year is 2018
